search
2,497 Data sources

  • DE
  • FR
  • PK
  • EU

  • more_vert
  • more_vert
  • The CAZy database describes the families of structurally-related catalytic and carbohydrate-binding modules (or functional domains) of enzymes that degrade, modify, or create glycosidic bonds.

    more_vert
  • This repository hosts the research output of the French Institute for Demographic Studies. The interface is available in French and English.

    more_vert
  • more_vert
  • more_vert
  • Orphadata provides the scientific community with comprehensive, quality datasets related to rare diseases and orphan drugs from the Orphanet knowledge base, in reusable formats.

    more_vert
  • This site provides access to the research output of the institution. The interface is available in German or English. Users may set up an RSS feed to be alerted to new content. Many items are not available as full-text.

    more_vert
  • more_vert
  • The basic principle in the Biocidal Products Regulation ((EU) No 528/2012 (BPR)) is that a biocidal product must be authorised before it can be made available on the market or used in the European Economic Area (EEA) and Switzerland. The active substance is evaluated and, provided the criteria are fulfilled, is then approved in a specified product-type. The data on this page is active substance/product-type centric. The database includes active substances in the Review Programme, active substances not in the Review Programme as well as substances in Annex I of the BPR.

    more_vert
2,497 Data sources
  • more_vert
  • more_vert
  • The CAZy database describes the families of structurally-related catalytic and carbohydrate-binding modules (or functional domains) of enzymes that degrade, modify, or create glycosidic bonds.

    more_vert
  • This repository hosts the research output of the French Institute for Demographic Studies. The interface is available in French and English.

    more_vert
  • more_vert
  • more_vert
  • Orphadata provides the scientific community with comprehensive, quality datasets related to rare diseases and orphan drugs from the Orphanet knowledge base, in reusable formats.

    more_vert
  • This site provides access to the research output of the institution. The interface is available in German or English. Users may set up an RSS feed to be alerted to new content. Many items are not available as full-text.

    more_vert
  • more_vert
  • The basic principle in the Biocidal Products Regulation ((EU) No 528/2012 (BPR)) is that a biocidal product must be authorised before it can be made available on the market or used in the European Economic Area (EEA) and Switzerland. The active substance is evaluated and, provided the criteria are fulfilled, is then approved in a specified product-type. The data on this page is active substance/product-type centric. The database includes active substances in the Review Programme, active substances not in the Review Programme as well as substances in Annex I of the BPR.

    more_vert